Clinical Trial Update: Aromatase Inhibitor Clinical Trial

View source ↗

Summary

An aromatase inhibitor clinical trial in breast cancer sponsored by the National Institute of General Medical Sciences has an unknown status in the provided sni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitor (generic) (aromatase inhibitor)

Snippet

Sponsor: National Institute of General Medical Sciences (NIGMS) | Conditions: Breast Cancer | Status: UNKNOWN